PAPER
Bis(4-hydroxythiazoles): Novel Functional and Switchable Fluorophores
2337
Crystal Data for 4a: C22H20N2O2S2, Mr = 408.52 g mol–1, red prism,
size 0.05 × 0.05 × 0.03 mm3, monoclinic, space group P21/c,
a = 4.9317(3), b = 10.1208(9), c = 19.491(2) Å, b = 95.265(5)°,
V = 968.7(1) Å3, T = –140 °C, Z = 2, rcalcd = 1.401 g cm–3,
m(MoKa) = 2.96 cm–1, F(000) = 428, 9060 reflections in h(–5/6),
k(–13/11), l(–25/25), measured in the range 2.10° £ Q £ 27.47°,
5,5¢-Bis(4-methoxyphenyl)-2,2¢-bithiazole-4,4¢-diol (3c)
Following the typical procedure using 1c (1.1 equiv) and 2 (1
equiv); red powder; yield: 70%; mp 348–350 °C.
IR (ATR): 2954, 2553, 1504, 1404, 1246, 1053, 840 cm–1.
1H NMR (250 MHz, DMSO-d6): d = 11.67 (s, 2 H), 7.69 (d, J = 8.8
Hz, 4 H), 6.99 (d, J = 8.8 Hz, 4 H), 3.77 (s, 6 H).
13C NMR (62.5 MHz, DMSO-d6): d = 158.6, 158.0, 151.6, 128.0,
124.1, 114.8, 110.7, 55.6.
MS (EI): m/z (%) = 412 (7) [M+], 233 (11), 151 (100), 108 (41).
completeness Qmax = 99.8%, 2220 independent reflections, Rint
=
0.1459, 1346 reflections with Fo > 4s(Fo), 167 parameters, 0 re-
straints,
R1obs = 0.0539,
wR2obs = 0.1091,
R1all = 0.1165,
wR2all = 0.1317, GOOF = 0.969, largest difference peak and hole:
0.320/–0.488 e Å–3.
UV/Vis (DMSO): lmax = 466 nm; deprotonated (KOH) lmax
=
=
Crystal Data for 16: C40H30N4O8S4 2 C3H7NO, Mr = 969.11 g mol–1,
red-brown prism, size 0.05 × 0.05 × 0.04 mm3, monoclinic, space
group P21/n, a = 10.4220(4), b = 21.1752(9), c = 10.6172(4) Å,
b = 107.599(2)°, V = 2233.42(15) Å3, T = –140 °C, Z = 2,
620 nm.
Fluorescence (DMSO): lmax = 535 nm; deprotonated (KOH) lmax
649 nm.
r
calcd = 1.441 g cm–3, m (MoKa) = 2.8 cm–1, F(000) = 1012, 13706
Anal. Calcd for C20H16N2O4N2: C, 58.24; H, 3.91; N, 6.79; S, 15.55.
Found: C, 58.01; H, 4.05; N, 6.65; S, 15.84.
reflections in h(–13/13), k(–21/27), l(–13/13), measured in the
range 2.26° £ Q £ 27.49°, completeness Qmax = 99.4%, 5101 inde-
pendent reflections, Rint = 0.0577, 3746 reflections with Fo
>
=
4,4¢-Diethoxy-5,5¢-diphenyl-2,2¢-bithiazole (4a)
4s(Fo), 306 parameters, 0 restraints, R1obs = 0.0614, wR2
obs
Compound 3a (1 mmol) was dissolved in DMSO (20 mL). Under
stirring, NaH (1.1 mmol, 60% suspension) was added. After 10 min,
EtI (1.1 mmol) was added dropwise to the deep-violet soln. The
mixture was stirred until the reaction was complete (TLC monitor-
ing, CHCl3). Then, H2O (50 mL) was added and the formed suspen-
sion was filtered off and the crude product was dried in vacuo. The
obtained solid was dissolved in CH2Cl2 and filtered through a short
silica gel column and the solvent was removed; yield: 93%; light-
red crystals; mp 201 °C.
0.1225, R1all = 0.0959, wR2all = 0.1395, GOOF = 1.075, largest dif-
ference peak and hole: 0.604/–0.328 e Å–3.
4-Hydroxythiazoles 3a–c, 6a,b, 9, 10 and 12; Typical Procedure
A mixture of pyridine (0.87 g, 11 mmol), the corresponding thio-
amide 2 or 5 (10 mmol) and the corresponding ethyl bromophenyl-
acetate 1 or sulfanylacetate (11 mmol) was stirred under argon at
100–110 °C until the mixture solidified. After 1 h, EtOH (30 mL)
was added and the mixture was stirred at r.t. for 30 min. After filtra-
tion the crude product was recrystallized (EtOH–DMF) and dried in
vacuo.
IR (ATR): 1519, 1469, 1330, 1060, 760, 686 cm–1.
1H NMR (250 MHz, CDCl3): d = 7.81 (d, J = 8.6 Hz, 4 H), 7.42–
7.36 (m, 4 H), 7.28–7.25 (m, 2 H), 4.61 (q, J = 7.1 Hz, 4 H), 1.52 (t,
J = 7.0 Hz, 6 H).
13C NMR (62.5 MHz, CDCl3): d = 159.1, 153.1, 131.5, 128.7,
126.9, 126.8, 113.9, 66.6, 15.2.
MS (EI): m/z (%) = 408 (89) [M+], 380 (8), 231 (12), 203 (33), 121
(100), 77 (31).
5,5¢-Diphenyl-2,2¢-bithiazole-4,4¢-diol (3a)
Following the typical procedure using 1a (1.1 equiv) and 2 (1
equiv); orange-red crystals or powder; yield: 40–60%; mp 335–338
°C.
IR (ATR): 2699, 2557, 1411, 1369 1211, 1001, 751 cm–1.
1H NMR (250 MHz, DMSO-d6): d = 11.94 (s, 2 H), 7.78 (d, J = 7.5
Hz, 4 H), 7.44 (dd, J = 7.5 Hz, 4 H), 7.28 (dd, J = 7.3 Hz, 2 H).
13C NMR (62.5 MHz, DMSO-d6): d = 159.1, 158.2, 152.7, 131.7,
129.4, 127.2, 126.6.
MS (EI): m/z (%) = 352 (12) [M+], 203 (13), 121 (100), 77 (19).
UV/Vis (THF): lmax = 442 nm.
Fluorescence (THF): lmax = 500 nm.
Anal. Calcd for C14H10N2OS: C, 64.68; H, 4.93; N, 6.86; S, 15.70.
Found: C, 64.55; H, 5.11; N, 6.99; S, 15.41.
UV/Vis (DMSO):
max = 580 nm.
lmax = 445 nm; deprotonated (KOH)
Pyridine-2,4,6-tricarbothioamide (5b)
l
Pyridine-2,4,6-tricarbonitrile (0.25 g, 1 mmol,) was dissolved in
DMSO (40 mL). Aq (NH4)2S soln (1.5 mL, 48%) was added in one
portion. The mixture was stirred for 30 min and then H2O (125 mL)
was added. After 1 h, the crude product was filtered off, recrystal-
lized (DMF) and dried in vacuo; yellow powder; yield: 56%; mp
>300 °C (decomp.).
Fluorescence (DMSO): lmax = 528 nm; F = 96% (Rh 6G), t1/2
2.8 ns; deprotonated (KOH) lmax = 656 nm. F = 22% (Rh 6G).
=
5,5¢-Bis(4-bromophenyl)-2,2¢-bithiazole-4,4¢-diol (3b)
Following the typical procedure using 1b (1.1 equiv) and 2 (1
equiv); deep red powder; yield: 75%; mp >360 °C.
IR (ATR): 3371, 3263, 3159, 1581, 1420, 1265, 644 cm–1.
IR (ATR): 2654, 2553, 1380, 1423, 1207, 1006, 808 cm–1.
1H NMR (250 MHz, DMSO-d6): d = 11.77 (s, 2 H), 7.73 (d,
J = 8.6 Hz, 2 H), 7.63 (d, J = 8.6 Hz, 2 H).
13C NMR (62.5 MHz, DMSO-d6): d = 159.5, 153.2, 132.2, 131.1,
128.6, 119.6, 110.2.
1H NMR (250 MHz, DMSO-d6): d = 10.51–10.06 (m, 6 H), 8.95 (s,
2 H).
13C NMR (62.5 MHz, DMSO-d6): d = 197.6, 192.6, 149.4, 148.9,
123.9.
MS (EI): m/z (%) = 256 (100) [M+], 239 (16), 222 (58), 206 (20),
180 (19), 60 (58).
MS (EI): m/z (%) = 512 (17), 510 (23), 508 (14), 283 (31), 201
(100), 199 (93), 121 (50), 120 (69).
HRMS (ESI): m/z calcd for C8H8N4S3: 255.9911; found: 255.9921.
UV/Vis (DMSO): lmax = 350 nm.
UV/Vis (DMSO): lmax = 455 nm; deprotonated (KOH) lmax
530 nm.
=
=
2,2¢-Pyridine-2,5-diylbis(5-phenylthiazol-4-ol) (6a)
Following the typical procedure using 1a (2.1 equiv) and 5a (1
equiv); yellow powder; yield: 21%; mp >300 °C (decomp).
Fluorescence (DMSO): lmax = 520 nm; deprotonated (KOH) lmax
645 nm.
Synthesis 2011, No. 14, 2334–2339 © Thieme Stuttgart · New York